Light fractionation significantly increases the efficacy of photodynamic therapy using BF-200 ALA in normal mouse skin

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  De Bruijn, Henriëtte S ^a   Brooks, Sander ^a   Van Der Ploeg Van Den Heuvel, Angélique ^a   Ten Hagen, Timo L M ^a   De Haas, Ellen R M ^a   Robinson, Dominic J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; BF 200 5 AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; BF-200 ALA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASAL CELL CARCINOMA; BLEACHING; CONTROLLED STUDY; ENDOTHELIUM CELL; EX VIVO STUDY; FEMALE; FRACTIONATION; ILLUMINATION; IN VIVO STUDY; LIGHT FRACTIONATION; MOUSE; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; PHOTODYNAMIC THERAPY; PIG; SKIN; SKIN DEFECT; UTERINE CERVIX CARCINOMA IN SITU; VAGINAL INTRAEPITHELIAL NEOPLASIA; ANALOGS AND DERIVATIVES; ANIMAL; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; METABOLISM; OUTBRED STRAIN; PHOTOCHEMOTHERAPY; PRECLINICAL STUDY; PROCEDURES; RADIATION DOSE FRACTIONATION; VASCULARIZATION;

AMINOLEVULINIC ACID; ANIMALS; ANIMALS, OUTBRED STRAINS; DOSE FRACTIONATION; DRUG EVALUATION, PRECLINICAL; ENDOTHELIAL CELLS; FEMALE; MICE; MICROSCOPY, FLUORESCENCE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; SKIN; SUS SCROFA;

EID: 84960540401     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0148850     Document Type: Article

References (44)

1. Morton C, McKenna K, Rhodes L. Guidelines for topical photodynamic therapy: update. Br J Dermatol. 2008;159(6):1245-1266. doi: 10.1111/j.1365-2133.2008.08882.x PMID: 18945319
2. Braathen LR, Szeimies RM, Basset-Seguin N, Bissonnette R, Foley P, Pariser D, et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: An international consensus. J Am Ac Dermatol. 2007;56(1):125-143.
3. Morton C, Szeimies RM, Sidoroff A, Wennberg AM, Basset-Seguin N, Calzavara-Pinton P, et al. European Dermatology Forum Guidelines on topical photodynamic therapy. Eur J Dermatol. 2015; PMID: 26065545.
4. Kawczyk-Krupka A, Waskowska J, Raczkowska-siostrzonek A, Kosciarz-Grzesiok A, Kwiatek S, Straszak D, et al. Comparison of cryotherapy and photodynamic therapy in treatment of oral leukoplakia. Photodiagnosis PhotodynTher 2012;9(2):148-155 doi: 10.1016/j.pdpdt.2011.12.007 PMID: 22594985
5. Jerjes W, Upile T, Hamdoon Z, Mosse CA, Akram S, Hopper C. Photodynamic therapy outcome for oral dysplasia. Lasers Surg Med 2011;43(3):192-199. doi: 10.1002/lsm.21036 PMID: 21412802
6. Hillemanns P, Garcia F, Petry KU, Dvorak V, Sadovsky O, Iversen OE, et al. A randomized study of hexaminolevulinate photodynamic therapy in patients with cervical intraepithelial neoplasia 1/2. Am J Obstet Gynecol. 2015;212(4):465.e1-7
7. Helgesen AL, Warloe T, Pripp AH, Kirschner R, Peng Q, Tanbo T, et al. Vulvovaginal photodynamic therapy versus topical corticosteroids in genital erosive lichen planus: A randomized controlled trial. Br J Dermatol. 2015 jul 20 doi: 10.1111/bjd.14033 PMID: 26189484
8. Choi MC, Kim MS, Lee GH, Jung SG, Park H, Joo WD, et al. Photodynamic therapy for premalignant lesions of the vulva and vagina: A long-term follow-up study. Lasers Surg Med 2015 jul 14 doi: 10.1002/lsm.22384 PMID: 26174756
9. Fotinos N, Campo MA, Popowycz F, Gurny R, Lange N. 5-Aminolevulinic acid derivatives in photomedicine: characteristics, application and perspectives. Photochem Photobiol. 2006;82:994-1015. PMID: 16542112
10. Gerritsen MJ, Smits T, Kleinpenning MM, van de Kerkhof PC, van Erp PE. Pretreatmentto enhance protoporphyrin IX accumulation in photodynamic therapy. Dermatology. 2009;218(3):193-220. doi: 10.1159/000183753 PMID: 19077380
11. Oh EK, Jin SE, Kim JK, Park JS, Park Y, Kim CK. Retained topical delivery of 5-aminolevulinic acid using cationic ultradeforamble liposomes for photodynamic therapy. Eur J PharmSci. 2011;44:149-157. PMID: 21782942
12. Blake E, Allen J, Curnow A. The effects of protoporphyrin IX-induced photodynamic therapy with and without iron chelation on human squamous carcinoma cells cultured under normoxic, hypoxic and hyperoxiccondictions. Photodiagnosis Photodyn Ther. 2013;10(4):575-582. doi: 10.1016/j.pdpdt. 2013.06.006 PMID: 24284114
13. Anand S, Wilson C, Hasan T, Maytin EV. Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy. Cancer Res. 2011;71(18):6040-6050. doi: 10.1158/0008-5472. CAN-11-0805 PMID: 21807844
14. Van der Veen N, Hebeda KM, de Bruijn HS, Star WM. Photodynamic effectiveness and vasoconstriction in hairless mouse skin after topical 5-aminolevulinic acid and single-ortwo-fold illumination. Photochem Photobiol. 1999;70:921-929. PMID: 10628304
15. De Bruijn HS, van der Veen N, Robinson DJ, Star WM. Improvement of systemic 5-aminolevulinic acid photodynamic therapy in-vivo using light fractionation with a75-minute interval. Cancer Res. 1999;59:901-904. PMID: 10029082
16. Robinson DJ, de Bruijn HS, de Wolf J, Sterenborg H JCM, Star WM. Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect. Photochem Photobiol. 2000;72:794-802. PMID: 11140268
17. Star WM, van 't Veen AJ, Robinson DJ, Munte K, de Haas ERM, Sterenborg H JCM. Topical 5-aminolevulinic acid mediated photodynamic therapy of superficial basal cell carcinoma using two light fractions with a two hour interval: long-term follow-up. Acta Derm Venereol. 2006;86:412-417. PMID: 16955185
18. De Haas ERM, Kruijt B, Sterenborg H J CM, Neumann HAM, Robinson DJ. Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy. J Invest Dermat. 2006;126:2679-2686.
19. De Vijlder HC, Sterenborg H J CM, Neumann HAM, Robinson DJ, de Haas ERM. Light fractionation significantly improves the response of superficial basal cell carcinoma to ALA-PDT: Five-year follow-up of a randomized, prospective trial. Acta Dermatol Venereol. 2012;92:641-647.
20. De Bruijn HS, van der Ploeg-van den Heuvel A, Sterenborg H J CM, Robinson DJ. Fractionated illumination after topical application of 5-aminolevulinic acid on normal skin of hairless mice; The influence of the dark interval. J Photochem Photobiol B. 2006;85:184-190. PMID: 16945548
21. Robinson DJ, de Bruijn HS, Star WM, Sterenborg H J CM. Dose and timing of the first light fraction in two fold illumination schemes for topical ALA-mediated photodynamic therapy of hairless mouse skin. Photochem Photobiol. 2003;77:319-323. PMID: 12685661
22. De Bruijn HS, de Haas ERM, Hebeda KM, van der Ploeg-van den Heuvel A, Sterenborg H J CM, Neumann HAM, et al. Light fractionation does not enhance the efficacy of methyl 5-aminolevulinate mediated photodynamic therapy in normal mouse skin. Photochem Photobiol Sci. 2007;6:1325-1331. PMID: 18046489
23. Middelburg TA, de Bruijn HS, van der Ploeg-van den Heuvel A, Neumann HA, Robinson DJ. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin. Photodiagnosis Photodyn Ther. 2013;10(4):703-709. doi: 10. 1016/j.pdpdt.2013.09.002 PMID: 24284130
24. De Bruijn HS, Sluiter W, van der Ploeg-van den Heuvel A, Sterenborg H J CM, Robinson DJ. Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy. Photodermatol Photoimmunol Photomed. 2006;22:238-246. PMID: 16948825
25. De Bruijn HS, Casas AG, Di Venosa G, Gandara L, Sterenborg H J CM, Battle A, et al. Light fractionated ALA-PDT enhances therapeutic efficacy in vitro; The influence of PpIX concentration and illumination parameters. Photochem Photobiol Sci. 2013;12(2):241-245. doi: 10.1039/c2pp25287b PMID: 23108451
26. Moan J, Ma LW, Juzeniene A, Iani V, Jezunas P, Apricena F, et al. Pharmacology of protoporphyrin IX in nude mice after application of ALA and ALA esters. Int J Cancer 2003;103:132-135. PMID: 12455066
27. Middelburg TA, de Vijlder HC, de Bruijn HS, van der Ploeg-van den Heuvel A, Neumann HA, de Haas ER, et al. Topical photodynamic therapy using different porphyrin precursors leads to differences in vascular photosensitization and vascular damage in normal mouse skin. Photochem Photobiol. 2014;90(4):896-902. doi: 10.1111/php. 12271 PMID: 24628584
28. Dirschka T, Radny P, Dominicus R, Mentsing H, Bruning H, Jenne L, et al. Long term (6 and 12 months) follow-up of two prospective, randomised, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolevulinate for the treatment of actinic keratosis. Br J Dermatol. 2013;168(4):825-836. doi: 10.1111/bjd.12158 PMID: 23252768
29. Neittaanmaki-Perttu N, Karppinen TT, Gronroos M, Tani TT, Snellman E. Daylight photodynamic therapy for actinic keratoses: A randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinicacid nanoemulsion (BF-200) with methyl-5-aminolaevulinate. Br J Dermatol. 2014;171(5):1172-1180. doi: 10.1111/bjd.13326 PMID: 25109244
30. Maisch T, Santarelli F, Schreml S, Babilas P, Szeimies R-M. Fluorescence induction of protoporphyrin IX by a new 5-aminolevulinic acid nanoemulsion used for photodynamic therapy in a full-thickness exvivo skin model. Experimental Dermatology 2010;19:e302-e305. doi: 10.1111/j.1600-0625.2009. 01001.x PMID: 19845760
31. Seynhaeve ALB, Hoving S, Schipper D, Vermeulen CE, aan de Wiel-Ambagtsheer G, van Tiel ST, et al. Tumor Necrosis Factor a Mediates Homogeneous Distribution of Liposomes in Murine Melanoma that Contributes to a better Tumor Response. Cancer Res. 2007;67:9455-9462. PMID: 17909055
32. Maisch T, Bosl C, Szeimies RM, Love B, Abels C. Determination of the antibacterial efficacy of a new porphyrin-based photosensitizer against MRSA ex vivo. Photochem Photobiol Sci. 2007;6:545-551. PMID: 17487307
33. De Vijlder HC, Sterenborg H J CM, Neumann HAM, Robinson DJ, de Haas ERM. Light Fractionation Significantly Improves the Response of Superficial Basal Cell Carcinoma to Aminolaevulinic Acid Photodynamic Therapy: Five-year Follow-up of a Randomized, Prospective Trial. Acta Derm Venereol. 2012;92(6):641-647. doi: 10.2340/00015555-1448 PMID: 22964973
34. Robinson DJ, de Bruijn HS, van der Veen N, Stringer MR, Brown SB, Star WM. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: The effect of light dose and irrandiance and the resulting biological effect. Photochem Photobiol. 1999;69(1):61-70.
35. Juzeniene A, Juzenas P, Iani V, Moan J. Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model. Photochem Photobiol. 2002;76(3):329-334. PMID: 12403455
36. Lesar A, Padgett M, O'Dwyer M, Ferguson J, Mosely H. Fluorescence induced by aminolevulinic acid and methyl aminolevulinate on normal skin. Photodiagnosis Photodyn Ther. 2007;4(4):224-229. doi: 10.1016/j.pdpdt.2007.09.002 PMID: 25047556
37. De Bruijn HS, Meijers C, van der Ploeg-van den Heuvel A, Sterenborg H J CM, Robinson DJ. Microscopic localisation of protoporphyrin IX in normal mouse skin after topical application of 5-aminolevulinic acid or methyl-5 aminolevulinate. J Photochem Photobiol B. 2008;92(2):91-97. PMID: 18571933
38. Dreher F, Walde P, Walther P, Werhli E. Interaction of a lecithin microemulsion gel with human stratum corneumand its effect on transdermal transport. J Contr Rel. 1997;45:131-140.
39. Foldvari M, Badea I, Wettig S, Baboolal D, Kumar P, Louise Creagh A, et al. Topical delivery of interferon alpha by biphasic vesicles: Evidence for a novel nanopathway across the stratum corneum. Mol Pharm. 2010;7:751-762. doi: 10.1021/mp900283x PMID: 20349952
40. Zellmer S, Pfeil W, Lasch J. Interaction of phosphatidylcholine liposomes with the human stratum corneum. Biochim Biophys Acta 1995;1237:176-182. PMID: 7632711
41. Robinson DJ, de Bruijn HS, van der Veen N, Stringer MR, Brown SB, Star WM. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: The effect of light dose and irradiance and the resulting biological effect. Photochem Photobiol. 1998;67(1):140-149. PMID: 9477772
42. Moan J, On the diffusion length of singlet oxygen in cells and tissues. J Photochem Photobiol B. 1990;6:343-344.
43. Ratcliffe SL, Matthews EK. Modification of the photodynamic action of delta-aminolevulinic acid (ALA) on rat pancreatoma cells by mitochondrial benzodiazepine receptor ligands. Br J Cancer 1995;71(2):300-305. PMID: 7841044
44. Kriska T, Korytowski W, Girotti AW. Role of mitochondrial cardiolopin peroxidation in apoptotic photokilling of 5-aminolevuliniate-treated tumor cells. Arch Biochem Biophys. 2005;433(2):435-446. PMID: 15581600